Navigation Links
Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors
Date:4/4/2011

SAN FRANCISCO and ILLKIRCH, France, April 5, 2011 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that new data from Phase 1 and 2 clinical studies of JX-594 were presented in an oral presentation at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) over the weekend at the Internationales Congress Centrum in Berlin, Germany.

The data from abstract #LB-283, entitled "JX-594, A Targeted Multi-Mechanistic Oncolytic Poxvirus, is Well-Tolerated and Exhibits Anti-Tumor Activity in Patients with Primary Liver Cancer and Liver Metastases," were presented by Caroline Breitbach, Ph.D., director of translational research.

"We are pleased to present these data on JX-594 at the EASL meeting, as they provide further evidence that both primary liver cancer and metastases to the liver can be treated safely with JX-594, with transient flu-like symptoms being the most common adverse events.  Anti-cancer activity continues to be clearly demonstrated in a broad spectrum of common solid tumor types," said David H. Kirn, M.D., president and chief executive officer of Jennerex.

"We look forward to reporting additional clinical results in patients with advanced liver cancer from two ongoing studies—a randomized Phase 2 trial of JX-594 evaluating survival across two dose groups, and a Phase 2 clinical trial evaluating JX-594 in combination with sorafenib," added Philippe Archinard, chairman and chief executive officer of Transgene.

Clinical Results

This presentation highlighted data from 35 patients with either primary liver cancer, known as hepatocellular carcinoma (HCC), or cancer metastases to the liver
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
2. Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
3. Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
4. Jennerex Appoints Lara Longpre to Chief Operating Officer
5. Jennerex Appoints Gregory W. Schafer as Chief Financial Officer
6. Jennerex Announces Presentations at Upcoming Conferences
7. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
8. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
9. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
10. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
11. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Spring Bank Pharmaceuticals, Inc., ... of viral infections, today announced that it has initiated ... its investigational, once daily, oral therapy for the treatment ... HCV-infected patients and is designed to assess both the ... is a first-in-class drug for the treatment of chronic ...
(Date:5/23/2013)... Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s 1 ... on October 14 th -15 th in ... most innovative city in the world by the ... Nation." BrainTech Israel 2013 will showcase the latest ...
(Date:5/23/2013)... , May 23, 2013 ... announced today that the prize for ,Best Novel Idea, ... and Medical Emergency Teams International Conference, hosted this year ... was awarded to a clinical research team studying the ... California Hospital in Los Angeles . ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4
... (CRL) has invested in a low-dose, state-of-the-art CT machine ... Minnesota.  This advanced diagnostic system will help physicians reach ... care with a radiation dose up to 40% lower ... "The addition of the GE Healthcare Brightspeed Elite CT ...
... ECRI Institute ®, an independent ... improving patient care, today announces the launch of its ... to ECRI Institute,s SELECTplus™ healthcare technology advisory service. The ... intelligence to help hospitals and health systems select and ...
Cached Medicine Technology:Consulting Radiologists, Ltd. Announces Addition of a Low Dose Advanced Computed Tomography (CT) System 2ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions 2ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions 3
(Date:5/23/2013)... On April 29th, 2013, UV Technologies issued ... H7N9 cases and deaths. The headline read, " UV Technologies, ... in Northern Hemisphere as Available Daylight Increases .” In fact, ... , Quoting Kevin McGuire, president of UV Technologies, "The ... in the spring and leaves changing in the fall. The ...
(Date:5/23/2013)... Cheap Concert Tickets announces that Paul ... at stadiums throughout North America. This well known ticket ... concert tickets to help McCartney fans see Sir Paul live ... states that she is also offering the customer appreciation code ... a baby boomer, she is also a huge McCartney fan ...
(Date:5/23/2013)... 23 (HealthDay News) -- The sensation of itching is ... back to a small molecule released in the spinal ... Researchers say this molecule, known as natriuretic polypeptide ... central nervous system. Ultimately, this signal is experienced as ... mice are similar, the researchers concluded that a similar ...
(Date:5/23/2013)... By Dennis Thompson HealthDay Reporter , , THURSDAY, ... soda can damage teeth as badly as methamphetamine or ... at it side-to-side with ,meth mouth, or ,coke mouth, ... of damage more or less the same," said Dr. ... Temple University School of Dentistry in Philadelphia. Methamphetamine, ...
(Date:5/23/2013)... virus isolated from a person who died from H7N9 ... infect and be transmitted between ferrets. Ferrets are often ... efficient transmission of influenza virus between ferrets can provide ... occur in people. The research was supported, in part, ... part of the National Institutes of Health. , The ...
Breaking Medicine News(10 mins):Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Ferrets, pigs susceptible to H7N9 avian influenza virus 2
... Researchers at the Mayo Clinic campus in Florida ... form of dementia that affects the brain areas associated with personality, ... of the American Journal of Human Genetics , ... progranulin and sortilin they say might open new avenues ...
... has filed an Investigational New Drug (IND) application with the ... Phase I safety trials to test NSI-189, its first small ... a proprietary new chemical entity discovered by Neuralstem that stimulates ... brain that is believed to be involved in depression. ...
... and Ergonomics Society has just released the newest volume ... annual series. Volume 6 reflects editor Douglas H. ... of expertise that exists in the Society and the ... we know about specific areas of human factors/ergonomicsstate of ...
... HealthDay Reporter , WEDNESDAY, Nov. 17 (HealthDay ... nerves has a striking effect on lowering blood pressure ... trying multiple drugs, Australian researchers report. Although this ... six months -- the authors believe the approach, which ...
... Reinberg HealthDay Reporter , WEDNESDAY, Nov. 17 ... in some adult vaccination rates, U.S. health officials reported ... should be. "We needed vaccinations as infants and ... Susan J. Rehm, medical director of the National Foundation ...
... mysterious culprit that threatens headaches, stuffy noses, skin rash ... people worldwide drink wine. The discovery could help winemakers ... and whites with less potential to trigger allergy symptoms, ... Journal of Proteome Research . Giuseppe ...
Cached Medicine News:Health News:New insight into the cause of common dementia found by researchers at Mayo Clinic 2Health News:New insight into the cause of common dementia found by researchers at Mayo Clinic 3Health News:Neuralstem files FDA application for first drug therapy 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 3Health News:CDC Report Finds Adult Vaccination Rates Still Lagging 2Health News:CDC Report Finds Adult Vaccination Rates Still Lagging 3
40-well gradient cycler...
... a high quality, compact thermal cycler. In addition ... Mastercycler personal offers first-rate operational flexibility. Its universal ... x 0.2 ml tubes, 16 x 0.5 ml ... grid format. Like the Mastercycler and the Mastercycler ...
... instrument and custom filter wheels with ... The standard filter set includes: FAM/SYBR ... Red (585nm-610nm), Cy5 (635nm-665nm) and Cy3 ... Mx3005P analysis software, Beacon Designer oligo ...
... The system includes: Mx3005P instrument and ... of five (5) filters. The standard ... (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red (585nm-610nm), ... included: desktop computer, Mx3005P analysis software, ...
Medicine Products: